Showing 1,341 - 1,360 results of 122,865 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 1.81s Refine Results
  1. 1341
  2. 1342

    Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

    Published 2024
    “…RBP-4 was increased in the sitagliptin non-ischemic group (SIT-N) compared to CON-N. There was a significant decrease in RBP-4 in the sitagliptin ischemic (SIT-I) myocardium compared to CON-I to levels similar to the CON-N myocardium. …”
  3. 1343
  4. 1344
  5. 1345
  6. 1346
  7. 1347
  8. 1348
  9. 1349
  10. 1350
  11. 1351
  12. 1352

    Effects of Cyr61 and Wnt5a on regenerating vasculature and musculature. by Devon C. Snow-Lisy (798898)

    Published 2015
    “…Cyr61KD demonstrated a significant decrease in muscle percentage from 4 to 10 weeks (p<0.05), with levels significantly lower than Cyr61OX at both time points. …”
  13. 1353

    Assessment of indicators of vitamin A status in non-cirrhotic chronic hepatitis C patients by R.C. Santana (6516497)

    Published 2019
    “…Furthermore, more advanced stages of liver fibrosis were related to a decrease in serum vitamin A levels.</p></div>…”
  14. 1354

    Effects of conivaptan on brain water content (BWC), blood-brain-barrier (BBB) disruption, plasma and urine sodium and osmolality. by Emil Zeynalov (596088)

    Published 2015
    “…Following MCAO, Evans Blue (EB) extravasation index (I/C) was increased in vehicle treated mice, and reduced in conivaptan treated mice, naïve, n = 5, vehicle, n = 8, Conivaptan 0.2 mg, n = 8. (C, D) Conivaptan treatment of 0.2 mg resulted in an elevation of plasma sodium and osmolality, and decreased urine sodium and osmolality due to aquaresis. …”
  15. 1355
  16. 1356
  17. 1357
  18. 1358
  19. 1359
  20. 1360